Comorbidity of Anxiety Disorders and Substance Abusewith Bipolar Mood Disorders and Relationship with ClinicalCourse
-
Ali Reza Shafiee-Kandjani
,
Javad Golmirzaei
,
Salam Bakhshi
,
Shahrokh Amiri
,
Mohammad Ali Ghoreishizadeh
Abstract
Objective: Patients with bipolar mood disorder constitute a relatively large number of individuals hospitalized in psychiatric hospitals. This disorder is highly co-morbid with other psychiatric disorders and may effect their clinical course. The goal of this study was to determine the co-occurrence rate of anxiety disorders and substance abuse with bipolar mood disorders and their impact on clinical course.
Methods: 153 bipolar patients (type I) were selected among the hospitalized patients at Razi Psychiatric Hospital in Tabriz, Iran, from September 2007 to October 2008 through convenience sampling method. The participants were evaluated by a structured clinical interview based on DSM-IV criteria (SCID), Hamilton Rating Scale for Depression (HRSD) and Young Mania Rating Scale (YMRS).
Results: Co-morbidity of anxiety disorders was 43% . Occurrence of anxiety disorders was 26% for obsessive-compulsive disorder, 24.8% for generalized anxiety disorder, 3.9% for phobia and 2% for panic disorder. Co-morbidity of substance abuse was 7.2% and the highest occurrence of substance abuse was 5.2% for alcoholism and 3.9% for opium. No significant difference was observed between the severity of disease and duration of hospitalization in bipolar patients with or without anxiety disorder. The severity of disease and duration of hospitalization in bipolar patients with substance abuse was higher compared to bipolar patients without substance abuse (P<0.05).
Conclusions: This study suggests that there is a high co-morbidity between anxiety disorders and substance abuse with bipolar disorder. Further, this study suggests that co-occurrence of substance abuse disorder with bipolar disorder increases the severity of the disease and duration of hospitalization.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders .4th ed, text rev. Washington DC: American Psychiatric Association; 2000.
Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol 2006; 18: 1181-1211.
McIntyre RS, Soczynska JK, Bottas A, Bordbar K, Konarski JZ, Kennedy SH. Anxiety disorders and bipolar disorder: a review. Bipolar Disord 2006; 8: 665-676.
Azorin JM, Kaladjian A, Adida M, Hantouche EG, Hameg A, Lancrenon S, et al. Psychopathological Correlates of Lifetime Anxiety Comorbidity in Bipolar I Patients: Findings from a French National Cohort. Psychopathology 2009; 42: 380-386.
Lee JH, Dunner DL. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders. Depress Anxiety 2008; 25: 91-97.
McElroy SL, Altshuler LL, Suppes T, Keck PE , Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158: 420-426.
Sharma V, Mazmanian D, Persad E, Kueneman K. A comparison of comorbid patterns in treatment-resistant unipolar and bipolar depression. Can J Psychiatry 1995; 40:270-274.
Wittchen HU. critical issues in the evaluatim of comorbidity of psychiatry disorders. Br J Psychiatry 1996; 68 :9-16.
Salloum IM, Thase ME. Impact of substance abuse on the course and treatment of bipolar disorder. Bipolar Disord 2000 ; 2:269–280.
Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM. Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder. J Clin Psychiatry 2004; 65:1106-1113.
Masi G, Perugi G, Millepiedi S, Toni C, Mucci M, Bertini N, et al. Clinical and research implications of panic-bipolar comorbidity in children and adolescents. Psychiatry Res 2007; 153: 47-54.
Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3: 181–188.
Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003; 64:331-335.
Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: Data from the first 500 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry 2004; 161:2222-2229.
Tamam L. Comorbid anxiety disorders in bipolar disorder patients: a review. Turk Psikiyatri Derg 2007; 18 : 59-71.
Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord 2000; 2:191- 195.
El-Mallakh RS, Hollifield M. Comorbid anxiety in bipolar disorder alters treatment and prognosis. Psychiatr Q 2008; 79: 139-150.
Smith SM, Stinson FS, Dawson DA, Goldstein R, Huang B, Grant BF. Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2006 ; 36:987-998.
Huang B, Grant BF, Dawson DA, Stinson FS, Chou SP, Saha TD, et al. Race –ethnicity and the prevalence and co occurrence of diagnostic and statistical manual of mental disorder , Four the edition alcohol and drug use disorders and axis I and II disorders: united states ,2001 to 2002. Compr Psychiat 2006;47: 252-257.
First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders: Clinician Version(SCID-CV): Administration Booklet. American Psychiatric Press Inc ;1996.
Sharifi V, Asaadi SM, Mohammadi MR, Amini H, kaviani H, Semnani Y, et al. Reliability and feasibility of the Persian Translation of the Structured Clinical Interview for DSM-IV (SCID). Advances in Cognitive Science 2004; 6: 10-22.
Hedlund JL, Viewig BW. The Hamilton rating scale for depression: a comprehensive review. Journal of Operational Psychiatry 1979; 10: 149-165.
Young RC, Biggs JT, Ziegler VE. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429- 435.
Michalak EE, Murray G, Young AH, Lam RW. Burden of bipolar depression: impact of disorder and medications on quality of life. CNS Drugs 2008; 22: 389-406.
Freeman AJ, Youngstrom EA, Michalak E, Siegel R, Meyers OI, Findling RL. Quality of Life in Pediatric Bipolar Disorder. Pediatrics 2009; 123: 446-452.
Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure- mania. Psychiatry Res 1997; 73: 47–56.
Dilsaver SC, Chen YW. Social phobia, panic disorder and suicidality in subjects with pure and depressive mania. J Affec Disord 2003; 77: 173–177.
Dilsaver SC, Benazzi F, Akiskal HS, Akiskal KK. Post-traumatic stress disorder among adolescents with bipolar disorder and its relationship to suicidality. Bipolar Disord 2007; 9:649-655.
Kilbane EJ, Gokbayra NS, Galynker I, Cohen L, Tross S. A review of panic and suicide in bipolar disorder: does comorbidity increase risk? J Affect Disord 2009; 115: 1-10.
Pini S, Dell'Osso L, Mastrocinque C, Marcacci G, Papasogli A, Vignoli S, et al. Axis I comorbidity in bipolar disorder with psychotic features. Br J Psychiatry 1999; 175: 467-471.
Sonne SC, Brady KT, Morton WA.. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994;82: 349-352.
Young AH. Bipolar disorder: diagnostic conundrums and associated comorbidities. J Clin Psychiatry 2009; 70: e26.
Baethge C, Baldessarini RJ, Khalsa HM, Hennen J, Salvatore P, Tohen M. Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry 2005; 162:1008-10010.
Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988 ; 49:214–229.
Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 1996; 66: 17–31.
MacKinnon DF, Zamoiski R. Panic comorbidity with bipolar disorder: what is the manic-panic connection? Bipolar Disord 2006 ;8: 648- 664.
Nery FG, Stanley JA, Chen HH, Hatch JP, Nicoletti MA, Serap Monkul E, et al. Bipolar disorder comorbid with alcoholism: A magnetic resonance spectroscopy study. J Psychiatr Res 2009. (Article in Press).
Dineen Wagner K. Bipolar disorder and comorbid anxiety disorders in children and adolescents. J Clin Psychiatry 2006; 67:16- 20.
O’Connell RA, Mayo JA, Flatow L, Cuthbertson B, O’Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123–129.
Dalton EJ, Cate-Carter T, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: The role of co-morbid substance use disorders. Bipolar Disord 2003; 5:58 –61.
Winokur G, Turvey C, Akiskal HS, Coryell W, Solomon D, Leon A, et al. Alcoholism and drug abuse in three groups—bipolar I, unipolars and their acquaintances. J Affect Disord 1998; 50: 81–89.
Brady K, Casto S, Lydiard RB, Malcolm R, Arana G. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 1991 ;17: 389 –397.
Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: A 4-year prospective follow-up study of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47: 1106 –1111.
Healey C, Peters S, Kinderman P, McCracken C, Morriss R. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study. J Affect Disord 2009; 113 : 118–126.
| Files | ||
| Issue | Vol 4 No 3 (2009) | |
| Section | Articles | |
| Keywords | ||
| Anxiety Disorders Substance Abuse Bipolar Disorder Comorbidity Severity of Disease | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
